News archive search

Search the Newsreel

Search stored headlines and summaries, then narrow the results by company, country, sector, industry, source or date.

Showing
1–36
Matches
85
Sources here
13
Companies here
3
Search results Stored financial headlines

Active search

85 matching headlines

Ticker or company: ADLMain company stories
Clear
Latest

Stock Titan Market update

Cormorant Asset Management (ANL) discloses 3.98M Adlai Nortye ADS position

Cormorant Asset Management, LP and Bihua Chen have reported a beneficial ownership of 3,978,229 American Depositary Shares (ADS) in Adlai Nortye Ltd. (ANL), representing 6.77% of the ADS-equivalent class. This holding is managed through investment funds advised by Cormorant, with Cormorant Global Healthcare Master Fund, LP holding entitlement to dividends or sale proceeds for over 5% of the …

Adlai Nortye Ltd. (ANL) holder Venrock group discloses 9.64M-share, 4.4% stake

The Venrock group has filed an updated beneficial ownership report for Adlai Nortye Ltd. (ANL), disclosing a 4.4% stake, equivalent to 9,638,193 Class A ordinary shares, as of June 30, 2026. This ownership is held through various Venrock Healthcare entities, with each American Depositary …

ANL main company
Sharemaestro market context Trend signal active 52 weeks +690.9% ANL stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Search results

Matching headlines

External headlines link to their original source. Market context comes from stored weekly company data, not from an opinion about the article.

Adlai Nortye H1FY26 Results: Net loss falls 71% to $5.3m

Adlai Nortye Ltd. reported a significant improvement in its H1FY26 financial results, with EPS of $(0.04) compared to $(0.19) last year, and a net loss reduction of 71% to $5.3 million. This improvement was primarily driven by $13.056 million in licensing revenue from its …

ANL main company
Sharemaestro market context Trend signal active 52 weeks +690.9% ANL stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Adlai Nortye Ltd. Reports Unaudited First Half 2026 Financial Results and Highlights Recent Operational Progress

Adlai Nortye Ltd. announced its unaudited financial results for the first half of 2026, reporting a significant decrease in net loss to US$5.3 million and a rise in revenue to US$13.1 million, primarily from a licensing agreement. The company highlighted operational progress in its …

ANL main company
Sharemaestro market context Trend signal active 52 weeks +690.9% ANL stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Vera Bradley (NASDAQ:VRA) Share Price Crosses Above 200 Day Moving Average - Time to Sell?

Vera Bradley (NASDAQ:VRA) shares recently crossed above their 200-day moving average, trading at $3.40 against an average of $3.39, but remained below their 50-day average. Analyst sentiment is cautious with a "Reduce" rating, despite the company beating Q1 earnings expectations with a smaller loss …

VRA main company
Sharemaestro market context Trend signal active 52 weeks +58.0% VRA stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Adlai Nortye Ltd. Sponsored ADR (NASDAQ:ANL) Receives Average Recommendation of "Moderate Buy" from Analysts

Adlai Nortye Ltd. Sponsored ADR (NASDAQ:ANL) has received an average "Moderate Buy" recommendation from six analysts, with five recommending a buy and one a sell. The average 12-month price target for the stock is $24.25, and institutional investors currently own 35.21% of the company. …

ANL main company
Sharemaestro market context Trend signal active 52 weeks +690.9% ANL stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Adlai Nortye Ltd (ANL) Earnings Forecast: Future EPS & Revenue Growth Estimates

This article provides an earnings forecast for Adlai Nortye Ltd (ANL), highlighting that analysts predict a "Buy" trend based on the ratings of 6 analysts. The target price for ANL is forecasted at USD 28.600, representing a significant upside potential. However, it notes that …

ANL main company
Sharemaestro market context Trend signal active 52 weeks +690.9% ANL stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Vera Bradley Inc (VRA) Stock News Today

This article provides a brief update on Vera Bradley Inc (VRA) stock news. It notes the current stock price and market capitalization, stating that more news, earnings, analyst ratings, and key developments will be available soon. The content indicates that updates are pending.

VRA main company
Sharemaestro market context Trend signal active 52 weeks +58.0% VRA stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Vera Bradley Inc (VRA) Earnings Forecast: Future EPS & Revenue Growth Estimates

This article provides an earnings forecast for Vera Bradley Inc (VRA), detailing its current earnings forecast score, average price target of $5.50, and analyst ratings. Based on one analyst, the stock holds a "Hold" signal, with an expected revenue of $65.95M for the next …

VRA main company
Sharemaestro market context Trend signal active 52 weeks +58.0% VRA stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Adlai Nortye Ltd. (ANL) stock price, news, quote and history

This page provides a detailed overview of Adlai Nortye Ltd. (ANL), including its current stock price, historical data, and key financial metrics. It highlights the company's clinical-stage biotechnology focus, outlining its pipeline of pharmaceutical products in various trial phases for cancer treatment. The page …

ANL main company
Sharemaestro market context Trend signal active 52 weeks +690.9% ANL stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Adlai Nortye receives approval to begin trial in Australia By Investing.com

Adlai Nortye Ltd. has received approval from Australia’s Human Research Ethics Committee to initiate a phase I clinical trial for AN4035, an antibody drug conjugate targeting certain solid tumors. The trial will assess the safety and efficacy of AN4035, which targets CEACAM5-enriched RAS-addicted solid …

ANL main company
Sharemaestro market context Trend signal active 52 weeks +690.9% ANL stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Adlai Nortye director Lars Erik Birgerson files initial beneficial ownership statement

Adlai Nortye director Lars Erik Birgerson has filed an initial ownership report, revealing direct ownership of 166,668 American Depositary Shares as of March 18, 2026. This news brief was generated by Public Technologies using AI and is based on original content filed by Adlai …

ANL main company
Sharemaestro market context Trend signal active 52 weeks +690.9% ANL stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Adlai Nortye Announces Clinical Trial Notification Submission and HREC Approval for the Phase I Clinical Trial of Pan-RAS(ON) Inhibitor ADC AN4035 in Australia

Adlai Nortye has received HREC approval and submitted a Clinical Trial Notification for its Phase I clinical trial of AN4035 in Australia. AN4035 is a first-in-class CEACAM5-targeting, pan-RAS(ON) inhibitor-based antibody drug conjugate designed to treat CEACAM5-enriched RAS-addicted solid tumors. The company is also filing …

ANL main company
Sharemaestro market context Trend signal active 52 weeks +690.9% ANL stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Adlai Nortye (NASDAQ: ANL) secures ethics nod for AN4035 Phase I cancer trial

Adlai Nortye Ltd. (NASDAQ: ANL) has received Human Research Ethics Committee approval and submitted a Clinical Trial Notification in Australia to initiate a Phase I clinical trial for AN4035. AN4035 is a first-in-class, CEACAM5-targeting antibody drug conjugate (ADC) armed with a pan-RAS(ON) inhibitor payload, …

ANL main company
Sharemaestro market context Trend signal active 52 weeks +690.9% ANL stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Adlai Nortye Announces First-in-Class AN4035 Cleared for Phase I Clinical Development as First Pan-RAS(ON) ADC to Enter the Clinic

Adlai Nortye has announced that its first-in-class antibody-drug conjugate (ADC), AN4035, has been cleared for Phase I clinical trials. AN4035 targets CEACAM5 to inhibit pan-RAS(ON) in tumors, aiming to reduce systemic toxicity. The company has secured approval from Australia's HREC and is filing IND …

ANL main company
Sharemaestro market context Trend signal active 52 weeks +690.9% ANL stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Adlai Nortye starts Phase I trial for first-in-class pan-RAS(ON) inhibitor ADC AN4035 in Australia

Adlai Nortye Ltd. has initiated a Phase I clinical trial in Australia for AN4035, a novel antibody drug conjugate designed to target CEACAM5-enriched RAS-addicted tumors. This first-in-class pan-RAS(ON) inhibitor ADC aims to provide a targeted cancer treatment with reduced systemic toxicity. The trial will …

ANL main company
Sharemaestro market context Trend signal active 52 weeks +690.9% ANL stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Adlai Nortye Ltd. Revenue Breakdown – NASDAQ:ANL

Adlai Nortye Ltd. (NASDAQ: ANL) generated total revenue of $5.40 million USD last year. The majority of this revenue, $5.00 million USD, came from its Innovative Targeted and Immune-modulating Cancer Therapies segment. China was the primary geographical contributor, accounting for $5.00 million USD of …

ANL main company
Sharemaestro market context Trend signal active 52 weeks +690.9% ANL stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Saba Capital Management L.P. Invests $916,000 in Vera Bradley, Inc. $VRA

Saba Capital Management L.P. acquired 290,000 shares of Vera Bradley (NASDAQ:VRA) worth approximately $916,000, establishing a 1.02% stake in the company. Other hedge funds also made significant moves, with institutional investors collectively owning nearly 60% of the stock. Despite a consensus "Reduce" rating from …

VRA main company
Sharemaestro market context Trend signal active 52 weeks +58.0% VRA stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Vera Bradley Inc (VRA) Institutional Confidence

Vera Bradley Inc (VRA) has an institutional shareholding score of 3.00, placing it 29th out of 36 in the Textiles & Apparel industry. The institutional shareholding proportion is 37.02%, marking an 11.61% quarter-over-quarter decrease. The largest institutional shareholder is Bill Nygren | OAKMX, holding …

VRA main company
Sharemaestro market context Trend signal active 52 weeks +58.0% VRA stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Vera Bradley Inc - Detailed Introduction, Company Background, Business Scope, Financial Data, and Market Performance | TradingKey

This article provides a detailed profile of Vera Bradley Inc (VRA), a designer of women's handbags, luggage, and accessories, outlining its business segments, financial data, and market performance. It includes key company information such as its IPO date, address, and executive team, along with …

VRA main company
Sharemaestro market context Trend signal active 52 weeks +58.0% VRA stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Adlai Nortye Ltd (ANL) Valuation: PE, PB & Fair Value Analysis

This article provides a valuation analysis for Adlai Nortye Ltd (ANL), focusing on its P/E, P/B, and P/CF ratios. However, it states that relevant data for these metrics have not yet been disclosed by the company. The article also includes general stock information like …

ANL main company
Sharemaestro market context Trend signal active 52 weeks +690.9% ANL stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Adlai Nortye Ltd (ANL) Income Statement

This article provides the quarterly income statement for Adlai Nortye Ltd (ANL), detailing its financial performance, including total revenue, operating expenses, net income, and earnings per share for various quarters. It also includes an FAQ section explaining how to read an income statement, the …

ANL main company
Sharemaestro market context Trend signal active 52 weeks +690.9% ANL stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Vera Bradley Inc (VRA) Shareholder Structure: Major Shareholders & Institutional Holdings

This article details the shareholder structure of Vera Bradley Inc (VRA), listing major individual and institutional holders and their proportions. It also categorizes shareholders by type and tracks institutional shareholding and activity over recent quarters. The data indicates shifts in ownership, including increases and …

VRA main company
Sharemaestro market context Trend signal active 52 weeks +58.0% VRA stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Adlai Nortye Ltd (ANL) Dividends & Stock Splits: Historical Payouts and Event Timeline

This article provides details on the dividend and stock split history for Adlai Nortye Ltd (ANL). It indicates that the company has not distributed any dividends over the past five years. The current stock price, market cap, and other financial data are also presented.

ANL main company
Sharemaestro market context Trend signal active 52 weeks +690.9% ANL stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Adlai Nortye Ltd (ANL) Shareholder Structure: Major Shareholders & Institutional Holdings

This article details the shareholder structure of Adlai Nortye Ltd (ANL), listing major shareholders such as VR Adviser, LLC and Nortye International Ltd, along with their respective proportions. It also categorizes shareholders by type (e.g., Venture Capital, Corporation) and provides a history of institutional …

ANL main company
Sharemaestro market context Trend signal active 52 weeks +690.9% ANL stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Adlai Nortye Ltd (ANL) Cash Flow - Tradingkey.com

This article provides a detailed cash flow statement for Adlai Nortye Ltd (ANL), including quarterly and annual data for operating, investing, and financing activities. It also includes frequently asked questions (FAQs) defining various cash flow metrics and how they apply to ANL's financial performance. …

ANL main company
Sharemaestro market context Trend signal active 52 weeks +690.9% ANL stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Vera Bradley Inc (VRA) Income Statement

This article provides the quarterly and annual income statements for Vera Bradley Inc (VRA), offering detailed financial data such as total revenue, operating expenses, and net income. It also includes key financial metrics like basic and diluted earnings per share, alongside an FAQ section …

VRA main company
Sharemaestro market context Trend signal active 52 weeks +58.0% VRA stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Adlai Nortye Ltd (ANL) Risk Assessment: Volatility, Financial Risk & Investment Risk

This article provides a risk assessment for Adlai Nortye Ltd (ANL), detailing its volatility, financial risk, and investment risk metrics. It includes data such as maximum drawdown, realized volatility, return-to-drawdown ratio, and liquidity metrics, offering investors a comprehensive overview of the stock's risk profile. …

ANL main company
Sharemaestro market context Trend signal active 52 weeks +690.9% ANL stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Adlai Nortye Ltd (ANL) Institutional Confidence

This article provides details on the institutional confidence for Adlai Nortye Ltd (ANL), including its stock price, market cap, and a breakdown of institutional shareholdings. Key institutional holders like VR Adviser, LLC and Nortye International Ltd are listed, along with changes in their holdings. …

ANL main company
Sharemaestro market context Trend signal active 52 weeks +690.9% ANL stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Find financial news

Search the Newsreel

Use one field or combine several. Results are newest first.

Evidence context